SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

Karen M. Krueger; Natasha Halasa; Michael G. Ison

doi:10.1053/j.ajkd.2021.10.003

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

Karen M. Krueger, Natasha Halasa, Michael G. Ison^*

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	162-163
Number of pages	2
Journal	American Journal of Kidney Diseases
Volume	79
Issue number	2
DOIs	https://doi.org/10.1053/j.ajkd.2021.10.003
State	Published - Feb 2022

ASJC Scopus subject areas

Nephrology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.ajkd.2021.10.003

Cite this

@article{8c3721df3b5b4d1b8a64957cc4fd20ff,

title = "SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?",

author = "Krueger, {Karen M.} and Natasha Halasa and Ison, {Michael G.}",

note = "Funding Information: Karen M. Krueger, MD, Natasha Halasa, MD, MPH, and Michael G. Ison, MD, MS. Dr Ison received research support from National Center for Advancing Translational Sciences grant UL1TR001422. Dr Ison reports research support, paid to Northwestern University, from AiCuris, GlaxoSmithKline, Janssen, and Shire; he is a paid consultant for Adagio, AlloVir, Celltrion, Cidara, Genentech, Roche, Janssen, Shionogi, and Viracor Eurofins; he is also a paid member of DSMBs from Janssen, Merck, SAB Biotherapeutics, Sequiris, Takeda, and Vitaeris. The other authors declare that they have no relevant financial interests. Received October 5, 2021 in response to an invitation from the journal. Direct editorial input from an Associate Editor and a Deputy Editor. Accepted in revised form October 25, 2021. Funding Information: Dr Ison received research support from National Center for Advancing Translational Sciences grant UL1TR001422. ",

year = "2022",

month = feb,

doi = "10.1053/j.ajkd.2021.10.003",

language = "English (US)",

volume = "79",

pages = "162--163",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - SARS-CoV-2 Vaccine in Dialysis Patients

T2 - Time for a Boost?

AU - Krueger, Karen M.

AU - Halasa, Natasha

AU - Ison, Michael G.

N1 - Funding Information: Karen M. Krueger, MD, Natasha Halasa, MD, MPH, and Michael G. Ison, MD, MS. Dr Ison received research support from National Center for Advancing Translational Sciences grant UL1TR001422. Dr Ison reports research support, paid to Northwestern University, from AiCuris, GlaxoSmithKline, Janssen, and Shire; he is a paid consultant for Adagio, AlloVir, Celltrion, Cidara, Genentech, Roche, Janssen, Shionogi, and Viracor Eurofins; he is also a paid member of DSMBs from Janssen, Merck, SAB Biotherapeutics, Sequiris, Takeda, and Vitaeris. The other authors declare that they have no relevant financial interests. Received October 5, 2021 in response to an invitation from the journal. Direct editorial input from an Associate Editor and a Deputy Editor. Accepted in revised form October 25, 2021. Funding Information: Dr Ison received research support from National Center for Advancing Translational Sciences grant UL1TR001422.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85121217499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121217499&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2021.10.003

DO - 10.1053/j.ajkd.2021.10.003

M3 - Editorial

C2 - 34922790

AN - SCOPUS:85121217499

SN - 0272-6386

VL - 79

SP - 162

EP - 163

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 2

ER -

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this